We are live on ! Find out more
JUNO

Juno Therapeutics, Inc.
JUNO

Delisted

JUNO was delisted on the 5th of March, 2018.

Back to rankings

157 hedge funds and large institutions have $1.55B invested in Juno Therapeutics, Inc. in 2017 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 52 increasing their positions, 48 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

22% more capital invested

Capital invested by funds: $1.27B → $1.55B (+$281M)

12% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 26

8% more repeat investments, than reductions

Existing positions increased: 52 | Existing positions reduced: 48

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

1% less funds holding

Funds holding: 159 → 157 (-2)

26% less call options, than puts

Call options by funds: $13.1M | Put options by funds: $17.7M

Holders
157
Holders Change
-2
Holders Change %
-1.26%
% of All Funds
3.91%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
29
Increased
52
Reduced
48
Closed
26
Calls
$13.1M
Puts
$17.7M
Net Calls
-$4.61M
Net Calls Change
+$3.68M

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$89.5M
2
Norges Bank
Norges Bank
Norway
+$17.9M
3
ACH
ArrowMark Colorado Holdings
Colorado
+$15.9M
4
Goldman Sachs
Goldman Sachs
New York
+$15.3M
5
CAM
Cormorant Asset Management
Massachusetts
+$13.9M

Top Sellers

Rank Fund Capital Flow
1
SCM
Scopia Capital Management
New York
-$33.5M
2
State Street
State Street
Massachusetts
-$8.62M
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$4.42M
4
AQR Capital Management
AQR Capital Management
Connecticut
-$3.76M
5
Citigroup
Citigroup
New York
-$3.64M
Name Holding Trade Value Shares
Change 		Change in
Stake
Charles Schwab
26
Charles Schwab
California
$6.37M +$381K +17,758 +7%
Bank of New York Mellon
27
Bank of New York Mellon
New York
$5.83M +$154K +7,165 +3%
Brown Advisory
28
Brown Advisory
Maryland
$5.56M – – –
AIM
29
ARK Investment Management
Florida
$5.51M +$2.28M +106,291 +75%
Susquehanna International Group
30
Susquehanna International Group
Pennsylvania
$5.08M -$4.42M -205,887 -47%
DADC
31
D.A. Davidson & Co
Montana
$4.85M +$52.6K +2,453 +1%
Deutsche Bank
32
Deutsche Bank
Germany
$4.77M -$43.7K -2,038 -0.9%
AG
33
Artal Group
Luxembourg
$4.44M – – –
RSCM
34
Rock Springs Capital Management
Maryland
$4.37M – – –
BC
35
Broadfin Capital
New York
$3.9M +$3.77M +175,700 New
TCIM
36
TIAA CREF Investment Management
New York
$3.84M -$164K -7,642 -4%
GC
37
Guggenheim Capital
Illinois
$3.35M +$92.1K +4,292 +3%
PP
38
Peconic Partners
New York
$3.33M +$3.22M +150,000 New
New York State Common Retirement Fund
39
New York State Common Retirement Fund
New York
$2.81M +$21 +1 +0%
California State Teachers Retirement System (CalSTRS)
40
California State Teachers Retirement System (CalSTRS)
California
$2.77M -$124K -5,800 -4%
Wells Fargo
41
Wells Fargo
California
$2.69M +$1.83M +85,516 +238%
CGL
42
Clarius Group LLC
Washington
$2.62M – – –
PHS
43
PFM Health Sciences
California
$2.54M -$107K -4,973 -4%
Swiss National Bank
44
Swiss National Bank
Switzerland
$2.31M – – –
SL
45
SIB LLC
New York
$2.22M – – –
Hudson Bay Capital Management
46
Hudson Bay Capital Management
Connecticut
$2.22M +$2.14M +100,000 New
IHM
47
Iguana Healthcare Management
New York
$2.22M +$2.14M +100,000 New
Canada Pension Plan Investment Board
48
Canada Pension Plan Investment Board
Ontario, Canada
$2.1M +$1.07M +49,700 +111%
US Bancorp
49
US Bancorp
Minnesota
$2.09M – – –
Group One Trading
50
Group One Trading
Illinois
$2.04M -$1.34M -62,518 -40%
1
2
3 4 5

JUNO Hedge Fund Activity: Q1 2017 in Review

157 of the 4,018 institutional investors tracked by Wall St. Rank reported a position in Juno Therapeutics, Inc. (JUNO) for Q1 2017, worth a combined $1.55B — up 22% from $1.27B a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new JUNO positions and 26 closed out — a net gain of 3 holders — while 52 added to existing stakes and 48 trimmed.

The largest buyer was BlackRock, adding an estimated $89.5M. The largest seller was Scopia Capital Management, exiting entirely with an estimated $33.5M sold.

  • 157 institutional investors held Juno Therapeutics, Inc. (JUNO) as of Q1 2017, down from 159 in Q4 2016.
  • Funds reported $1.55B of Juno Therapeutics, Inc. stock for Q1 2017, up 22% quarter-over-quarter.
  • 29 funds opened new Juno Therapeutics, Inc. positions in Q1 2017 and 26 closed out, a net change of +3 holders.
  • The largest Juno Therapeutics, Inc. buyer in Q1 2017 was BlackRock, an estimated $89.5M added.
  • The largest Juno Therapeutics, Inc. seller in Q1 2017 was Scopia Capital Management, an estimated $33.5M sold.

Based on aggregated 13F filings for Q1 2017.